- Science
- Clinical Trials
- Guide to Clinical Trials Your participation makes a difference
- Clinical Trials in Children Designed to improve kids' health
- Data and Results Sharing our Results
- Integrity and Transparency Building Trust
- Diversity Equity and Representation
- Plain Language Study Results Trial Result Summaries
- Expanded Access & Compassionate Use Possible Treatment Options
- Find a Trial
- Areas of Focus
- Rare Disease Smaller populations but big impact
- Internal Medicine Extending lifespans worldwide
- Inflammation & Immunology Treatment at the molecular level
- Vaccines Preventing the spread of infections
- Oncology The science of optimism
- Anti Infectives Combatting an evolving risk
- Areas of Innovation
- Gene Therapy Breakthroughs become treatments
- Medicinal Sciences The next generation of science
- Precision Medicine Developing tailored medicines
- Maternal Immunization Protecting newborns at the start
- mRNA Technology Unleashing the next wave of scientific innovations
- Diseases & Conditions
- Coronavirus Resources
- Product Pipeline
- Research Sites
- Clinical Trials
- Products
- How Drugs are Made
- Branded vs. Generic Learn the difference
- Biologics & Biosimilars Cures found in nature
- Commitment to Quality Maintaining the highest standards
- Global Supply Strategic manufacturing locations
- Manufacturing Sites Where medicine is made in the U.S.
- Medicine Safety
- Health Literacy Learning to be well
- Treatment Choices Learning about treatment decisions
- Partnering With Patients Helping others by reporting side effects
- Tips for Patients Preventing medication errors
- Reporting Adverse Events
- Counterfeiting Preventing medication errors
- Product Safety
- Product List
- Product Contacts
- PfizerPro for Professionals
- Patient Assistance Programs
- Distributors
- How Drugs are Made
- Stories
- Newsroom
- About
- People
- Executives Our senior-most leadership
- Board Members The people steering our company
- Scientists Our experts making discoveries
- Patient Stories Our patients
- Colleague Stories Our colleagues
- Responsibility
- Ethics & Compliance Each of us is responsible
- Responsible Business Breakthroughs that change patients’ lives
- Patient Advocacy & Engagement Putting Patients First
- Global Impact Meeting urgent needs worldwide
- Diversity, Equity, and Inclusion Everyone has something to offer
- Environmental Sustainability Our responsiblity to the environment
- Human Rights Furthering dignity and worth
- Health & Safety
- Intellectual Property The benefits of fair competition
- EHS Governance
- Misinformation
- Programs & Policies
- Grants Support for independent research
- Political Partnership Supporting like-minded organizations
- Working with Healthcare Professionals Collaboration to improve lives
- Prescription Value & Pricing How to lower patient costs
- Privacy Principles Commitment to personal data privacy
- Ready for Cures Improving Access to Medicines
- Transparency in Grants Committed to Disclosure
- Policy Positions
- Investors
- Investors Overview Information for stockholders
- Why Invest Why to join us in our mission
- Events & Presentations Calendar of upcoming events
- Financial Reports Quarterly reports and more
- Investor News Announcements about our performance
- Stock Information Charts and data
- Shareholder Services Information on stock transactions
- Corporate Governance
- Corporate Governance Overview Gaining insight into our performance
- Board Committees & Charters Defining the corporate structure
- The Pfizer Board Policies Ensuring ethical leadership
- Corporate Governance FAQs Learn more about our approach
- Contact Our Directors Email any of our Directors
- Purpose
- History
- Careers
- Partners
- People
Disease Education Information: Inflammation
Inflammation is a critical response to potential danger signals and damage to organs in our body. But with autoimmune diseases such as rheumatoid arthritis, lupus, ulcerative colitis, Crohn’s disease, and many others, our own immune system turns against our organs.
These painful and debilitating conditions take an immense toll on people’s quality of life and many of these diseases are poorly managed by existing treatments that provide only symptomatic relief.
For decades, doctors relied on steroids to suppress immune response. Though an important option, steroids come with many potentially harmful side effects.
Fortunately, science has continued to advance, and today we have the opportunity to transform the management of inflammatory diseases with new classes of therapies that target other key proteins and pathways in the body.
Inflammation & Immunology Resources
The medicines available today have taken an average of 12 years to develop. With dedication, creativity, and science, we can significantly cut that time.
Areas of Focus
Revolutionary medicines have the power to enrich and extend life across many disease areas. Explore our latest innovations.
Rare Disease
View All Rare Disease
Explore all of our disease and condition-related resources to learn more about your diagnosis and treatment options.
Gene Therapy
Acromegaly
Duchenne Muscular Dystrophy
Gaucher Disease
Growth Hormone Deficiency
Hemophilia
Sickle Cell
Transthyretin Amyloidosis
Internal Medicine
View All Internal Medicine
We’re developing therapies to treat, slow, or prevent disease progression and improve the quality of life for patients with obesity, type 2 diabetes, and cardiovascular and kidney diseases.
Inflammation & Immunology
View All Inflammation & Immunology
We look for treatments that provide more than just symptom relief, in order to address the root cause of chronic inflammatory diseases at a molecular level
Vaccines
View All Vaccines
Vaccines are the single most important innovation in the science of health to significantly reduce the threat of diseases that were once widespread and oftentimes fatal.
Oncology
View All Oncology
Cancer treatment needs to be transformed across the entire landscape to significantly improve the lives of cancer patients worldwide.
Anti Infectives
View All Anti Infectives
Anti-infectives are medicines that work to prevent or treat infections, including antibacterials, antivirals, antifungals, and antiparasitic medications.
Anti-infectives
Antimicrobial Resistance
AMR Prevention
Antimicrobial Surveillance
Antimicrobial Stewardship
Our Commitment as a Global Leader
Environmental Protection
How Drugs Are Made
The medicines available today have taken an average of 12 years to develop. With dedication, creativity, and science, we can significantly cut that time.
Pipeline Snapshot as of October 29, 2024
- 00Phase 1
- 00Phase 2
- 00Phase 3
- 00Registration
- 00Total
The People Behind the Treatments
Meet the people behind our medicines. Our experts make discoveries that give the world cutting-edge treatments for conditions that span the range from the common cold to rare diseases.
Associate Research Fellow and Group Leader, Chemical Development Active Pharmaceutical Ingredients
Senior Director, Oncology Medicinal Chemistry Synthesis and Analytical Group
Senior Vice President and Chief Scientific Officer, Internal Medicine Research Unit
Show More
Associate Research Fellow and Group Leader, Chemical Development Active Pharmaceutical Ingredients
Senior Director, Oncology Medicinal Chemistry Synthesis and Analytical Group
Senior Vice President and Chief Scientific Officer, Internal Medicine Research Unit
Associate Research Fellow and Group Leader, Chemical Development Active Pharmaceutical Ingredients
Senior Director, Oncology Medicinal Chemistry Synthesis and Analytical Group
Senior Vice President and Chief Scientific Officer, Internal Medicine Research Unit
Show More
Associate Research Fellow and Group Leader, Chemical Development Active Pharmaceutical Ingredients
Senior Director, Oncology Medicinal Chemistry Synthesis and Analytical Group
Senior Vice President and Chief Scientific Officer, Internal Medicine Research Unit